课题基金 / 基金详情

HYPOPITUITARY CONTROL AND COMPLICATIONS

HYPOPITUITARY CONTROL AND COMPLICATIONS
垂体功能低下的控制和并发症
批准号：
6115824
负责人：
DAVID L KLEINBERG
金额：
$2.1万
依托单位：
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6115824
关键词：
clinical research endocrine disorder chemotherapy hormone therapy human subject human therapy evaluation longitudinal human study pituitary dwarfism skeletal disorder chemotherapy somatotropin

项目摘要

项目成果

DAVID L KLEINBERG的其他基金

相关文献

中文摘要
翻译
本研究的主要目的是记录与选择不接受生长激素替代治疗的类似患者相比，接受生长激素替代治疗的生长激素缺乏成人的长期安全性结局。 本研究的次要目的是建立成人中安全有效的重组人生长激素剂量的特定算法，并评价重组人生长激素替代治疗与其他激素治疗联合使用的效果。
英文摘要
The primary objective of this study is to document the long-term safety outcomes in somatotropin-deficient adults who are given somatropin replacement therapy as compared to similar patients who elect not to be treated with somatropin replecement therapy. The secondary goals of the study are to establish specific algorithms for safe and effective somatropin dosage in adults and to evaluate the effect of somatropin replacement therapy in conjunction with other hormonal therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SURGICAL DEBULKING PLUS OCTREOTIDE VERSUS OCTREOTIDE ALONE IN ACROMEGALY
PREVALENCE OF GROWTH HORMONE DEFICIENCY & RANGES OF IGF-1 IN NORMAL ELDERLY
PREVALENCE OF GROWTH HORMONE DEFICIENCY & RANGES OF IGF-1 IN NORMAL ELDERLY
Prevalence of Growth Hormone Deficiency & Ranges of IGF-1 in Normal Elderly